Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000160461 | SCV000211026 | benign | not specified | 2014-09-08 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000206507 | SCV000259982 | uncertain significance | Familial cancer of breast | 2015-08-16 | criteria provided, single submitter | clinical testing | This sequence change falls in the 3'UTR of the CHEK2 gene. It does not change the encoded amino acid sequence of the CHEK2 protein. This variant is present in population databases (rs121908710, 0.02%) and has been reported in the literature. ClinVar contains an entry for this variant (RCV000160461, RCV000119290 ). In summary, this is rare change that is not expected to impact CHEK2 protein. However the evidence is insufficient at this time to prove that conclusively. It has been classified as a Variant of Uncertain Significance. |
Counsyl | RCV000206507 | SCV000488398 | uncertain significance | Familial cancer of breast | 2016-03-18 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000160461 | SCV000594111 | uncertain significance | not specified | 2016-10-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000584174 | SCV000689619 | likely benign | Hereditary cancer-predisposing syndrome | 2015-09-08 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000206507 | SCV001141344 | likely benign | Familial cancer of breast | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV000160461 | SCV004243011 | likely benign | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
Institute. |
RCV000119290 | SCV000154114 | not provided | not provided | no assertion provided | not provided | ||
Department of Pathology and Laboratory Medicine, |
RCV001355148 | SCV001549942 | likely benign | Malignant tumor of breast | no assertion criteria provided | clinical testing | The CHEK2 c.*7T>C variant was not identified in the literature. The variant was identified in dbSNP (ID: rs121908710) as "With other allele", ClinVar (classified as benign by GeneDx; as likely being by Color; as uncertain significance by three submitters). The variant was identified in control databases in 40 of 260056 chromosomes at a frequency of 0.0002 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: European in 7 of 121970 chromosomes (freq: 0.00006), Ashkenazi Jewish in 33 of 9956 chromosomes (freq: 0.003), while the variant was not observed in the African, Other, Latino, East Asian, Finnish, and South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |